DOCSLIB.ORG

Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Published OnlineFirst October 22, 2018; DOI: 10.1158/1078-0432.CCR-18-1153 Cancer Therapy: Preclinical Clinical Cancer Research Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma Fabienne Desmots1,2, Mikael€ Roussel1,2,Celine Pangault1,2, Francisco Llamas-Gutierrez3,Cedric Pastoret1,2, Eric Guiheneuf2,Jer ome^ Le Priol2, Valerie Camara-Clayette4, Gersende Caron1,2, Catherine Henry5, Marc-Antoine Belaud-Rotureau5, Pascal Godmer6, Thierry Lamy1,7, Fabrice Jardin8, Karin Tarte1,9, Vincent Ribrag4, and Thierry Fest1,2 Abstract Purpose: Follicular lymphoma arises from a germinal cen- is enriched in the potent inducer of PRDM1 and IL21, highly ter B-cell proliferation supported by a bidirectional crosstalk produced by Tfhs. In follicular lymphoma carrying CREBBP with tumor microenvironment, in particular with follicular loss-of-function mutations, we found a lack of IL21-mediated helper T cells (Tfh). We explored the relation that exists PRDM1 response associated with an abnormal increased between the differentiation arrest of follicular lymphoma cells enrichment of the BCL6 protein repressor in PRDM1 gene. and loss-of-function of CREBBP acetyltransferase. Moreover, in these follicular lymphoma cells, pan-HDAC Experimental Design: The study used human primary cells inhibitor, vorinostat, restored their PRDM1 response to IL21 obtained from either follicular lymphoma tumors character- by lowering BCL6 bound to PRDM1. This finding was rein- ized for somatic mutations, or inflamed tonsils for normal forced by our exploration of patients with follicular lympho- germinal center B cells. Transcriptome and functional analyses ma treated with another pan-HDAC inhibitor. Patients were done to decipher the B- and T-cell crosstalk. Responses showed an increase of plasma cell identity genes, mainly were assessed by flow cytometry and molecular biology PRDM1 and XBP1, which underline the progression of follic- including ChIP-qPCR approaches. ular lymphoma B cells in the differentiation process. Results: Conversely to normal B cells, follicular lymphoma Conclusions: Our data uncover a new mechanism by which cells are unable to upregulate the transcription repressor, pan-HDAC inhibitors may act positively to treat patients with PRDM1, required for plasma cell differentiation. This defect follicular lymphoma through the induction of the expression occurs although the follicular lymphoma microenvironment of plasma cell genes. the microenvironment including IL21. This latter is a potent Introduction þ inducer of PCs and is produced by GC CD4 helper T cells called Adaptive immune responses involve the formation of germinal follicular helper T cells (Tfh; ref. 1). Akin to most cytokines, IL21 centers (GC), which are specialized structures allowing the dif- activates mainly JAK3/STAT3 signaling pathways (2), which are ferentiation of high-affinity B cells into long-lived memory B cells known to play a highly selective role in PC differentiation (3) and and plasma cells (PC). PCs are generated through specific tran- apoptosis, depending on the context (4). In humans, blockade of scriptional programs influenced by numerous signals delivered by IL21 inhibits PC generation. Tfh interacting with IL21 receptor expressing GC B cells could thus impact B-cell destiny via the 1Universite de Rennes, Etablissement Francais¸ du Sang (EFS) de Bretagne, Inserm, MICMAC–UMR_S1236, Rennes, France. 2Laboratoire d'hematologie, delivery of IL21 signal (3, 5). Human PCs emerging through Centre Hospitalier Universitaire de Rennes, Rennes, France. 3Laboratoire IL21/pSTAT3 signaling enhancement has concomitantly upregu- d'Anatomie Pathologique, Centre Hospitalier de Rennes, Rennes, France. lated PRDM1/BLIMP1 and downregulated BCL6 gene expression 4Gustave Roussy Cancer Campus, DITEP, Villejuif, France. 5Laboratoire de (6, 7). PRDM1/BLIMP1 is considered as the master PC factor that Cytogen etique, Centre Hospitalier de Rennes, Rennes, France. 6Service antagonizes BCL6 which sustains the B-cell identity (8, 9). There- 7 d'Hematologie Clinique, CH Bretagne Atlantique, Vannes, France. Service fore, PRDM1/BLIMP1 and BCL6 mutually inhibit each other and d'Hematologie Clinique, Centre Hospitalier de Rennes, Rennes, France. 8Inserm 9 BCL6-related inhibition of PC generation is predominantly relat- U918, Centre Henri Becquerel, Rouen, France. Laboratoire d'Immunologie, PRDM1 Centre Hospitalier de Rennes, Rennes, France. ed to BCL6 binding at intron 3 of where BCL6 recruits MTA3, which acts as a corepressor (10). Moreover, this PRDM1 Note: Supplementary data for this article are available at Clinical Cancer Research Online (http://clincancerres.aacrjournals.org/). intronic region contains an enhancer bound by CREBBP (11). CREBBP acts as a transcriptional coactivator of many different Current address for E. Guiheneuf: Laboratoire d'Hematologie, CHU Amiens- transcription factors through its intrinsic acetylation function on Picardie, Amiens, France. histone but also on nonhistone proteins including BCL6. Indeed, Corresponding Author: Thierry Fest, Rennes 1 University, 2 avenue du Pr Leon CREBBP binds and acetylates BCL6, leading to the inactivation of Bernard, Rennes 35043, France. Phone: 332-9928-4127; Fax: 332-9928-4152; its transcriptional repressor function (12, 13). E-mail: [email protected] In follicular lymphoma, we demonstrated earlier that the doi: 10.1158/1078-0432.CCR-18-1153 tumor microenvironment is enriched for Tfhs that sustain neo- Ó2018 American Association for Cancer Research. plastic cells (14, 15). It is generally accepted in the field that www.aacrjournals.org OF1 Downloaded from clincancerres.aacrjournals.org on September 24, 2021. © 2018 American Association for Cancer Research. Published OnlineFirst October 22, 2018; DOI: 10.1158/1078-0432.CCR-18-1153 Desmots et al. 2.0 Array and strategy for raw data normalization and filtering Translational Relevance is detailed in Supplementary Materials and Methods. In a number of phase I/II clinical trials, HDACi therapies have shown clinical responses, including complete remissions Gene expression analysis in previously multitreated patients with follicular lymphoma. The relative quantification of gene expression was determined ÀDDC Even if multiple biological effects have been described for using the 2 t method, then normalized to at least an internal these drugs, no effect on the master plasma cell regulator gene, control gene (ABL1, GAPDH, and/or HPRT1) and relative to a PRDM1, has been so far described in the context of the calibrator control sample corresponding to a mix of cDNA of follicular lymphoma. Indeed, our study revealed that follicular peripheral blood mononuclear cells (PBMC) from several healthy lymphomas with a CREBBP loss-of-function (concerns more donors. Statistical analysis using GraphPad Prism Software used than 50% of follicular lymphomas) were unable to upregulate Mann–Whitney test. PRDM1 expression despite the presence of IL21 in the tumor microenvironment, a potent inductor of PRDM1. In this Flow cytometry analysis, tissue immunostaining, Western context, we found that pan-HDACi can restore PRDM1 expres- blotting, and FISH analysis sion as well as other plasma cell genes, indicating a possible All antibodies and technical details concerning protein expres- reinitiation of follicular lymphoma B-cell differentiation. Our sion and FISH analyses are in Supplementary Materials and results highlight one effect of pan-HDACis to overcome fol- Methods, Supplementary Table S4, and Supplementary Figs. licular lymphomas' differentiation blockade. S3, S4, and S8. Culture conditions and molecular analyses Cells were cultured for 2 hours before receiving indicated follicular lymphomas are tumors reflective of centrocytes that fail treatments for 24 hours, and then CD19/CD20 viable B cells to differentiate beyond the GC exit point. Purified follicular were collected and used for subsequent DNA and RNA extraction. lymphoma B cells compared with normal GC B cells does not Detailed procedures are given in Supplementary Materials and identify a radically opposed signature, but rather substantial Methods. modification of normal GC expression driving most likely by numerous genetic and epigenetic somatic modifications Somatic mutations assessment (14, 16–18). Both histone acetyl transferases, CREBBP and EP300, We performed the SureSelect targeted-capture strategy from are commonly mutated in follicular lymphoma and CREBBP loss- Agilent Technologies using a panel of 34 genes described previ- of-function affects preferentially H3K27 acetylation whose deple- ously (22) with subsequent paired-end sequencing on an Illumina tion leads to downregulation of genes involved in GC output HiSeq 1500 Platform (Illumina). For variants detection, SureCall (19). Interestingly, the expression of these genes can be restored software from Agilent technologies was used (see Supplementary after inhibition of HDAC3 (20). Materials and Methods, Supplementary Tables S2B and S3B). In this study, we assessed PRDM1 gene expression and regu- lation to achieve new insights on the differentiation blockade that Statistical analyses characterizes the follicular lymphoma. We showed that despite a Statistical analyses were performed with the GraphPad Prism functional capacity to activate the IL21/pSTAT3 signaling, non- software V5 (GraphPad Software) as indicated in Supplementary functional CREBBP follicular lymphoma cells were unable to Materials and Methods section. increase PRDM1 expression. In these follicular
Recommended publications
  • Activated Peripheral-Blood-Derived Mononuclear Cells

    Activated Peripheral-Blood-Derived Mononuclear Cells

    Transcription factor expression in lipopolysaccharide- activated peripheral-blood-derived mononuclear cells Jared C. Roach*†, Kelly D. Smith*‡, Katie L. Strobe*, Stephanie M. Nissen*, Christian D. Haudenschild§, Daixing Zhou§, Thomas J. Vasicek¶, G. A. Heldʈ, Gustavo A. Stolovitzkyʈ, Leroy E. Hood*†, and Alan Aderem* *Institute for Systems Biology, 1441 North 34th Street, Seattle, WA 98103; ‡Department of Pathology, University of Washington, Seattle, WA 98195; §Illumina, 25861 Industrial Boulevard, Hayward, CA 94545; ¶Medtronic, 710 Medtronic Parkway, Minneapolis, MN 55432; and ʈIBM Computational Biology Center, P.O. Box 218, Yorktown Heights, NY 10598 Contributed by Leroy E. Hood, August 21, 2007 (sent for review January 7, 2007) Transcription factors play a key role in integrating and modulating system. In this model system, we activated peripheral-blood-derived biological information. In this study, we comprehensively measured mononuclear cells, which can be loosely termed ‘‘macrophages,’’ the changing abundances of mRNAs over a time course of activation with lipopolysaccharide (LPS). We focused on the precise mea- of human peripheral-blood-derived mononuclear cells (‘‘macro- surement of mRNA concentrations. There is currently no high- phages’’) with lipopolysaccharide. Global and dynamic analysis of throughput technology that can precisely and sensitively measure all transcription factors in response to a physiological stimulus has yet to mRNAs in a system, although such technologies are likely to be be achieved in a human system, and our efforts significantly available in the near future. To demonstrate the potential utility of advanced this goal. We used multiple global high-throughput tech- such technologies, and to motivate their development and encour- nologies for measuring mRNA levels, including massively parallel age their use, we produced data from a combination of two distinct signature sequencing and GeneChip microarrays.
  • Microglia Emerge from Erythromyeloid Precursors Via Pu.1- and Irf8-Dependent Pathways

    Microglia Emerge from Erythromyeloid Precursors Via Pu.1- and Irf8-Dependent Pathways

    ART ic LE S Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways Katrin Kierdorf1,2, Daniel Erny1, Tobias Goldmann1, Victor Sander1, Christian Schulz3,4, Elisa Gomez Perdiguero3,4, Peter Wieghofer1,2, Annette Heinrich5, Pia Riemke6, Christoph Hölscher7,8, Dominik N Müller9, Bruno Luckow10, Thomas Brocker11, Katharina Debowski12, Günter Fritz1, Ghislain Opdenakker13, Andreas Diefenbach14, Knut Biber5,15, Mathias Heikenwalder16, Frederic Geissmann3,4, Frank Rosenbauer6 & Marco Prinz1,17 Microglia are crucial for immune responses in the brain. Although their origin from the yolk sac has been recognized for some time, their precise precursors and the transcription program that is used are not known. We found that mouse microglia were derived from primitive c-kit+ erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception. + lo − + − + These precursors developed into CD45 c-kit CX3CR1 immature (A1) cells and matured into CD45 c-kit CX3CR1 (A2) cells, as evidenced by the downregulation of CD31 and concomitant upregulation of F4/80 and macrophage colony stimulating factor receptor (MCSF-R). Proliferating A2 cells became microglia and invaded the developing brain using specific matrix metalloproteinases. Notably, microgliogenesis was not only dependent on the transcription factor Pu.1 (also known as Sfpi), but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required. Our data provide cellular and molecular insights into the origin and development of microglia. Microglia are the tissue macrophages of the brain and scavenge dying have the ability to give rise to microglia and macrophages in vitro cells, pathogens and molecules using pattern recognition receptors and in vivo under defined conditions.
  • The Transcription Factors C-Myb and GATA-2 Act Independently in The

    The Transcription Factors C-Myb and GATA-2 Act Independently in The

    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 5313-5318, May 1996 Medical Sciences The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis PAOLA MELOTrl AND BRUNO CALABRETTA Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, 233 South 10th Street, Philadelphia, PA 19107 Communicated by Sidney Weinhouse, Thomas Jefferson University, Philadelphia, PA, January 23, 1996 (received for review, October 20, 1995) ABSTRACT The transcription factors c-myb and GATA-2 erythromyeloid differentiation (7). This process appears to are both required for blood cell development in vivo and in rest in the ability of c-myb to activate the expression of vitro. However, very little is known on their mechanism(s) of hematopoiesis-specific targets such as c-kit,flt-3, GATA-1, and action and whether they impact on complementary or over- CD34, but not GATA-2 (7). The induction of c-kit and flt-3 lapping pathways of hematopoietic proliferation and differ- expression and the dependence of c-myb-transfected ES cells entiation. We report here that embryonic stem (ES) cells on the expression of these cytokine receptors for their prolif- transfected with c-myb or GATA-2 cDNAs, individually or in eration (7) strongly suggest that the up-regulation of growth combination, underwent hematopoietic commitment and dif- factor receptor levels is of fundamental importance for the ferentiation in the absence of added hematopoietic growth expansion of progenitor cells. In turn, such a process is factors but that stimulation with c-kit and flt-3 ligands en- probably a requirement for completion of the differentiation hanced colony formation only in the c-myb transfectants.
  • A PAX5-OCT4-PRDM1 Developmental Switch Specifies Human Primordial Germ Cells

    A PAX5-OCT4-PRDM1 Developmental Switch Specifies Human Primordial Germ Cells

    A PAX5-OCT4-PRDM1 Developmental Switch Specifies Human Primordial Germ Cells Fang Fang1,2, Benjamin Angulo1,2, Ninuo Xia1,2, Meena Sukhwani3, Zhengyuan Wang4, Charles C Carey5, Aurélien Mazurie5, Jun Cui1,2, Royce Wilkinson5, Blake Wiedenheft5, Naoko Irie6, M. Azim Surani6, Kyle E Orwig3, Renee A Reijo Pera1,2 1Department of Cell Biology and Neurosciences, Montana State University, Bozeman, MT 59717, USA 2Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA 3Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, School of Medicine; Magee Women’s Research Institute, Pittsburgh, PA, 15213, USA 4Genomic Medicine Division, Hematology Branch, NHLBI/NIH, MD 20850, USA 5Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. 6Wellcome Trust Cancer Research UK Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, UK. Correspondence should be addressed to F.F. (e-mail: [email protected]) 1 Abstract Dysregulation of genetic pathways during human germ cell development leads to infertility. Here, we analyzed bona fide human primordial germ cells (hPGCs) to probe the developmental genetics of human germ cell specification and differentiation. We examined distribution of OCT4 occupancy in hPGCs relative to human embryonic stem cells (hESCs). We demonstrate that development, from pluripotent stem cells to germ cells, is driven by switching partners with OCT4 from SOX2 to PAX5 and PRDM1. Gain- and loss-of-function studies revealed that PAX5 encodes a critical regulator of hPGC development. Moreover, analysis of epistasis indicates that PAX5 acts upstream of OCT4 and PRDM1. The PAX5-OCT4-PRDM1 proteins form a core transcriptional network that activates germline and represses somatic programs during human germ cell differentiation.
  • Cells Transformed by a V-Myb-Estrogen Receptor Fusion Differentiate Into Multinucleated Giant Cells

    Cells Transformed by a V-Myb-Estrogen Receptor Fusion Differentiate Into Multinucleated Giant Cells

    JOURNAL OF VIROLOGY, May 1997, p. 3760–3766 Vol. 71, No. 5 0022-538X/97/$04.0010 Copyright q 1997, American Society for Microbiology Cells Transformed by a v-Myb-Estrogen Receptor Fusion Differentiate into Multinucleated Giant Cells UTE ENGELKE, DUEN-MEI WANG, AND JOSEPH S. LIPSICK* Department of Pathology, Stanford University School of Medicine, Stanford, California 94305-5324 Received 22 October 1996/Accepted 29 January 1997 In order to make conditional alleles of the v-myb oncogene, we constructed and tested avian retroviruses which produce a number of different fusion proteins between v-Myb and the human estrogen receptor (ER). We found that the portion of the ER used in making these fusions profoundly affected their transcriptional activation. However, all the fusions tested were only weakly transforming in embryonic yolk sac assays and there was no direct correlation between the level of transcriptional activation and strength of oncogenic transformation. Nevertheless, transformation by a v-Myb-ER fusion was estrogen dependent, and upon with- drawal of the hormone, monocytic-lineage cells differentiated into multinucleated giant cells. Surprisingly, the withdrawal of estrogen caused a dramatic increase in the stability of the fusion protein, although it remained unable to promote cell growth or block differentiation. Conditional alleles of retroviral oncogenes have provided genes, have been isolated and analyzed in considerable detail powerful tools with which to dissect the mechanism of onco- (3, 4). A differential cDNA screen has identified a target gene, genic transformation and the biology of transformed cells (17, mim-1, which is directly activated by the Gag-Myb-Ets protein 29).
  • A Flexible Microfluidic System for Single-Cell Transcriptome Profiling

    A Flexible Microfluidic System for Single-Cell Transcriptome Profiling

    www.nature.com/scientificreports OPEN A fexible microfuidic system for single‑cell transcriptome profling elucidates phased transcriptional regulators of cell cycle Karen Davey1,7, Daniel Wong2,7, Filip Konopacki2, Eugene Kwa1, Tony Ly3, Heike Fiegler2 & Christopher R. Sibley 1,4,5,6* Single cell transcriptome profling has emerged as a breakthrough technology for the high‑resolution understanding of complex cellular systems. Here we report a fexible, cost‑efective and user‑ friendly droplet‑based microfuidics system, called the Nadia Instrument, that can allow 3′ mRNA capture of ~ 50,000 single cells or individual nuclei in a single run. The precise pressure‑based system demonstrates highly reproducible droplet size, low doublet rates and high mRNA capture efciencies that compare favorably in the feld. Moreover, when combined with the Nadia Innovate, the system can be transformed into an adaptable setup that enables use of diferent bufers and barcoded bead confgurations to facilitate diverse applications. Finally, by 3′ mRNA profling asynchronous human and mouse cells at diferent phases of the cell cycle, we demonstrate the system’s ability to readily distinguish distinct cell populations and infer underlying transcriptional regulatory networks. Notably this provided supportive evidence for multiple transcription factors that had little or no known link to the cell cycle (e.g. DRAP1, ZKSCAN1 and CEBPZ). In summary, the Nadia platform represents a promising and fexible technology for future transcriptomic studies, and other related applications, at cell resolution. Single cell transcriptome profling has recently emerged as a breakthrough technology for understanding how cellular heterogeneity contributes to complex biological systems. Indeed, cultured cells, microorganisms, biopsies, blood and other tissues can be rapidly profled for quantifcation of gene expression at cell resolution.
  • Recombinant PRDM1 Protein

    Recombinant PRDM1 Protein

    Recombinant PRDM1 protein Catalog No: 81277, 81977 Quantity: 20, 1000 µg Expressed In: Baculovirus Concentration: 0.4 µg/µl Source: Human Buffer Contents: Recombinant PRDM1 protein is supplied in 25 mM HEPES-NaOH pH 7.5, 300 mM NaCl, 10% glycerol, 0.04% Triton X-100, 0.5 mM TCEP. Background: PRDM1 (PR/SET Domain 1), also called as Beta-Interferon Gene Positive-Regulatory Domain I Binding Factor, or BLIMP1, is a transcription factor that acts as a repressor of beta-interferon gene expression. It mediates a transcriptional program in various innate and adaptive immune tissue-resident lymphocyte T cell types such as tissue resident memory T (Trm), natural killer (trNK) and natural killer T (NKT) cells and negatively regulates gene expression of proteins that promote the egress of tissue-resident T-cell populations from non-lymphoid organs. PRDM1 plays a role in the development, retention and long-term establishment of adaptive and innate tissue- resident lymphocyte T cell types in non-lymphoid organs, such as the skin and gut, but also in other nonbarrier tissues like liver and kidney, and therefore may provide immediate immunological protection against reactivating infections or viral reinfection (By similarity). Protein Details: Recombinant PRDM1 was expressed in a baculovirus expression system as the full length protein (accession number NP_001189.2) with an N-terminal FLAG tag. The molecular weight of PRDM1 is 93 kDa. Application Notes: This product was manufactured as described in Protein Details. Recombinant PRDM1 protein gel Where possible, Active Motif has developed functional or activity assays for 9% SDS-PAGE gel with Coomassie recombinant proteins.
  • Transcription Regulation of MYB: a Potential and Novel Therapeutic Target in Cancer

    Transcription Regulation of MYB: a Potential and Novel Therapeutic Target in Cancer

    Review Article Page 1 of 11 Transcription regulation of MYB: a potential and novel therapeutic target in cancer Partha Mitra1,2 1Pre-clinical Division, Vaxxas Pty. Ltd. Translational Research Institute, Woolloongabba QLD 4102, Australia; 2Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Woolloongabba QLD 4102, Australia Correspondence to: Partha Mitra. Pre-clinical Division, Vaxxas Pty. Ltd. Translational Research Institute, 37 Kent St., Woolloongabba QLD 4102, Australia; Queensland University of Technology, Translational Research Institute, 37 Kent St., Woolloongabba QLD 4102, Australia. Email: [email protected]; [email protected]. Abstract: Basal transcription factors have never been considered as a priority target in the field of drug discovery. However, their unparalleled roles in decoding the genetic information in response to the appropriate signal and their association with the disease progression are very well-established phenomena. Instead of considering transcription factors as such a target, in this review, we discuss about the potential of the regulatory mechanisms that control their gene expression. Based on our recent understanding about the critical roles of c-MYB at the cellular and molecular level in several types of cancers, we discuss here how MLL-fusion protein centred SEC in leukaemia, ligand-estrogen receptor (ER) complex in breast cancer (BC) and NF-κB and associated factors in colorectal cancer regulate the transcription of this gene. We further discuss plausible strategies, specific to each cancer type, to target those bona fide activators/co-activators, which control the regulation of this gene and therefore to shed fresh light in targeting the transcriptional regulation as a novel approach to the future drug discovery in cancer.
  • GATA2 Regulates Mast Cell Identity and Responsiveness to Antigenic Stimulation by Promoting Chromatin Remodeling at Super- Enhancers

    GATA2 Regulates Mast Cell Identity and Responsiveness to Antigenic Stimulation by Promoting Chromatin Remodeling at Super- Enhancers

    ARTICLE https://doi.org/10.1038/s41467-020-20766-0 OPEN GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super- enhancers Yapeng Li1, Junfeng Gao 1, Mohammad Kamran1, Laura Harmacek2, Thomas Danhorn 2, Sonia M. Leach1,2, ✉ Brian P. O’Connor2, James R. Hagman 1,3 & Hua Huang 1,3 1234567890():,; Mast cells are critical effectors of allergic inflammation and protection against parasitic infections. We previously demonstrated that transcription factors GATA2 and MITF are the mast cell lineage-determining factors. However, it is unclear whether these lineage- determining factors regulate chromatin accessibility at mast cell enhancer regions. In this study, we demonstrate that GATA2 promotes chromatin accessibility at the super-enhancers of mast cell identity genes and primes both typical and super-enhancers at genes that respond to antigenic stimulation. We find that the number and densities of GATA2- but not MITF-bound sites at the super-enhancers are several folds higher than that at the typical enhancers. Our studies reveal that GATA2 promotes robust gene transcription to maintain mast cell identity and respond to antigenic stimulation by binding to super-enhancer regions with dense GATA2 binding sites available at key mast cell genes. 1 Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO 80206, USA. 2 Center for Genes, Environment and Health, National Jewish Health, Denver, CO 80206, USA. 3 Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, ✉ CO 80045, USA. email: [email protected] NATURE COMMUNICATIONS | (2021) 12:494 | https://doi.org/10.1038/s41467-020-20766-0 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20766-0 ast cells (MCs) are critical effectors in immunity that at key MC genes.
  • Transcriptional Plasticity Drives Leukemia Immune Escape

    Transcriptional Plasticity Drives Leukemia Immune Escape

    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.23.457351; this version posted August 24, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Transcriptional plasticity drives leukemia immune escape Kenneth Eagle1,2*, Taku Harada1,*, Jérémie Kalfon3, Monika W. Perez1, Yaser Heshmati1, Jazmin Ewers1, Jošt Vrabič Koren4, Joshua M. Dempster3, Guillaume Kugener3, Vikram R. Paralkar5, Charles Y. Lin4 , Neekesh V. Dharia1,3, Kimberly Stegmaier1,3, Stuart H. Orkin1,6,† and Maxim Pimkin1,3,† 1. Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children’s Hospital, Harvard Medical School, Boston, MA 2. Ken Eagle Consulting, Houston, TX 3. Broad Institute of MIT and Harvard, Cambridge, MA 4. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 5. Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 6. Howard Hughes Medical Institute, Boston, MA * These authors contributed equally † These authors jointly supervised Correspondence to: [email protected], [email protected] ABSTRACT Relapse of acute myeloid leukemia (AML) after allogeneic bone marrow transplantation (alloSCT) has been linked to immune evasion due to reduced expression of major histocompatibility complex class II (MHC-II) proteins through unknown mechanisms. We developed CORENODE, a computational algorithm for genome-wide transcription network decomposition, that identified the transcription factors (TFs) IRF8 and MEF2C as positive regulators and MYB and MEIS1 as negative regulators of MHC-II expression in AML cells.
  • MYB Transcription Factors and Its Regulation in Secondary Cell Wall Formation and Lignin Biosynthesis During Xylem Development

    MYB Transcription Factors and Its Regulation in Secondary Cell Wall Formation and Lignin Biosynthesis During Xylem Development

    International Journal of Molecular Sciences Review MYB Transcription Factors and Its Regulation in Secondary Cell Wall Formation and Lignin Biosynthesis during Xylem Development Ruixue Xiao 1,2, Chong Zhang 2, Xiaorui Guo 2, Hui Li 1,2 and Hai Lu 1,2,* 1 Beijing Advanced Innovation Center for Tree Breeding by Molecular Design, Beijing Forestry University, Beijing 100083, China; [email protected] (R.X.); [email protected] (H.L.) 2 College of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing 100083, China; [email protected] (C.Z.); [email protected] (X.G.) * Correspondence: [email protected] Abstract: The secondary wall is the main part of wood and is composed of cellulose, xylan, lignin, and small amounts of structural proteins and enzymes. Lignin molecules can interact directly or indirectly with cellulose, xylan and other polysaccharide molecules in the cell wall, increasing the mechanical strength and hydrophobicity of plant cells and tissues and facilitating the long-distance transportation of water in plants. MYBs (v-myb avian myeloblastosis viral oncogene homolog) belong to one of the largest superfamilies of transcription factors, the members of which regulate secondary cell-wall formation by promoting/inhibiting the biosynthesis of lignin, cellulose, and xylan. Among them, MYB46 and MYB83, which comprise the second layer of the main switch of secondary cell-wall biosynthesis, coordinate upstream and downstream secondary wall synthesis-related transcription factors. In addition, MYB transcription factors other than MYB46/83, as well as noncoding RNAs, Citation: Xiao, R.; Zhang, C.; Guo, X.; hormones, and other factors, interact with one another to regulate the biosynthesis of the secondary Li, H.; Lu, H.
  • View / Download

    View / Download

    Thynn HN, Chen XF, Dong SS, Guo Y, Yang TL. Commentary: An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long-Range Chromatin Loop Formation. J Immunological Sci. (2020); 4(1): 6-9 Journal of Immunological Sciences Commentary Article Open Access Commentary: An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long- Range Chromatin Loop Formation Hlaing Nwe Thynn, Xiao-Feng Chen, Shan-Shan Dong, Yan Guo, Tie-Lin Yang* Key Laboratory of Biomedical Information Engineering of Ministry of Education, Biomedical Informatics & Genomics Center, School of Life Science and Technol- ogy, Xi’an Jiaotong University, Xi’an, Shaanxi 710049, P. R. China Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis Article Info Article Notes sharing similar pathogenic features. Genetic factors play important Received: February 14, 2020 (SSc) are two typical inflammatory systemic1 autoimmune diseases Accepted: March 20, 2020 roles in the pathogenesis of both diseases . We have witnessed huge success of genome-wide association studies (GWASs) in identifying *Correspondence: hundreds of susceptibility genetic variants associated with SLE Dr. Tie-Lin Yang, Ph.D., Key Laboratory of Biomedical Information Engineering of Ministry of Education, Biomedical and SSc, however, over 90% of which are located in noncoding Informatics & Genomics Center, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, Shaanxi into biological insights towards clinical applications. Currently, 710049, P. R. China; Telephone No: 86-29-82668463; Email: regions. It is challenging and important to translate GWAS findings [email protected]. compared with traditional genetic association studies, functional studies characterizing causal functional variants and downstream © 2020 Yang TL.